NOV C-Ter (Sisene Biotechnology)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameNOV C-Ter (Sisene Biotechnology)
Drug Alias Namerecombinant NOVCter (INSERM/University Rene Descartes)recombinant NOV (INSERM/Universite Rene Descartes)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsCorneal DiseasesEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSisene BiotechnologyInserm
Active IndicationsN/A
Inactive IndicationsCorneal DiseasesEye DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A